Asciminib provides better efficacy and favorable safety and tolerability vainvestigators-selected tyrosine kinase inhibitors(lS TKl) in newly diagnosed chronimyeloid leukemia(CML):results from the east Asia subgroup analysis of the pivotalASC4First study
刘兵城
中国医学科学院血液病医院(中国医学科学院血液学研究所)